CAQ
CAQ
Cambridge Acquisition Corp. Class A Ordinary SharesIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|
5-Year Trend Analysis
A comprehensive look at Cambridge Acquisition Corp. Class A Ordinary Shares's financial evolution and strategic trajectory over the past five years.
CAQ has a clear thematic focus on high-growth, emerging health and wellness technologies, which positions it to benefit if it can secure the right partner. Its current cost base is lean, with limited overhead and no legacy operational baggage. The absence of past acquisitions or complex assets also means there are no inherited integration issues or immediate impairment risks. Structurally, it retains the flexibility to design a transaction that could align with fast-growing niches and investor interest in these themes.
The financial profile shows severe weaknesses: no revenue, no cash, negative equity, and a heavy reliance on short-term obligations. Liquidity risk and going-concern risk are significant. Strategically, CAQ must compete with many better-capitalized buyers for a limited pool of attractive targets, under time pressure and within highly regulated industries that can shift quickly. Until a merger is identified and funded, there is material uncertainty around the company’s ability to stabilize its balance sheet and transition into a viable operating business.
The outlook is highly uncertain and heavily dependent on execution. If CAQ can raise or access sufficient capital, secure a strong target in its chosen sectors, and navigate regulatory and market headwinds, the combined entity could benefit from exposure to growing health and wellness trends. Conversely, failure to close a compelling deal, difficulties in funding obligations, or adverse regulatory developments in areas like hemp and psychedelics could leave the company constrained or force it into an unfavorable resolution. Current financial statements primarily highlight risk and the need for successful transaction execution rather than any existing operational strength.
About Cambridge Acquisition Corp. Class A Ordinary Shares
Cambridge Acquisition Corp. operates as an American blank check company. The company is located in the US.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|
5-Year Trend Analysis
A comprehensive look at Cambridge Acquisition Corp. Class A Ordinary Shares's financial evolution and strategic trajectory over the past five years.
CAQ has a clear thematic focus on high-growth, emerging health and wellness technologies, which positions it to benefit if it can secure the right partner. Its current cost base is lean, with limited overhead and no legacy operational baggage. The absence of past acquisitions or complex assets also means there are no inherited integration issues or immediate impairment risks. Structurally, it retains the flexibility to design a transaction that could align with fast-growing niches and investor interest in these themes.
The financial profile shows severe weaknesses: no revenue, no cash, negative equity, and a heavy reliance on short-term obligations. Liquidity risk and going-concern risk are significant. Strategically, CAQ must compete with many better-capitalized buyers for a limited pool of attractive targets, under time pressure and within highly regulated industries that can shift quickly. Until a merger is identified and funded, there is material uncertainty around the company’s ability to stabilize its balance sheet and transition into a viable operating business.
The outlook is highly uncertain and heavily dependent on execution. If CAQ can raise or access sufficient capital, secure a strong target in its chosen sectors, and navigate regulatory and market headwinds, the combined entity could benefit from exposure to growing health and wellness trends. Conversely, failure to close a compelling deal, difficulties in funding obligations, or adverse regulatory developments in areas like hemp and psychedelics could leave the company constrained or force it into an unfavorable resolution. Current financial statements primarily highlight risk and the need for successful transaction execution rather than any existing operational strength.
CEO
Brent Michael Cox